Skip to main content

BASES MOLECULARES DE LA ESCLEROSIS SISTEMICA: INTEGRANDO GENOMICA Y TRANSCRIPTOMICA

SAF2015-66761-P

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2015
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations

  • Márquez, Ana
  • Kerick, Martin
  • Zhernakova, Alexandra
  • Gutierrez-Achury, Javier
  • Chen, Wei-Min
  • Onengut-Gumuscu, Suna
  • González-Álvaro, Isidoro
  • Rodríguez-Rodríguez, Luis
  • Ríos-Fernández, Raquel
  • González-Gay, Miguel A.
  • Mayes, Maureen D.
  • Raychaudhuri, Soumya
  • Rich, Stephen S
  • Wijmenga, Cisca
  • Martín, J.
[Background] In recent years, research has consistently proven the occurrence of genetic overlap across autoimmune diseases, which supports the existence of common pathogenic mechanisms in autoimmunity. The objective of this study was to further investigate this shared genetic component. [Methods] For this purpose, we performed a cross-disease meta-analysis of Immunochip data from 37,159 patients diagnosed with a seropositive autoimmune disease (11,489 celiac disease (CeD), 15,523 rheumatoid arthritis (RA), 3477 systemic sclerosis (SSc), and 6670 type 1 diabetes (T1D)) and 22,308 healthy controls of European origin using the R package ASSET. [Results] We identified 38 risk variants shared by at least two of the conditions analyzed, five of which represent new pleiotropic loci in autoimmunity. We also identified six novel genome-wide associations for the diseases studied. Cell-specific functional annotations and biological pathway enrichment analyses suggested that pleiotropic variants may act by deregulating gene expression in different subsets of T cells, especially Th17 and regulatory T cells. Finally, drug repositioning analysis evidenced several drugs that could represent promising candidates for CeD, RA, SSc, and T1D treatment. [Conclusions] In this study, we have been able to advance in the knowledge of the genetic overlap existing in autoimmunity, thus shedding light on common molecular mechanisms of disease and suggesting novel drug targets that could be explored for the treatment of the autoimmune diseases studied., This work was supported by the following grants: SAF2015-66761-P from the Spanish Ministry of Economy and Competitiveness, P12-BIO-1395 from Consejería de Innovación, Ciencia y Tecnología, Junta de Andalucía (Spain), PI0493-2016 from Consejería de Salud, Junta de Andalucía (Spain) and the Cooperative Research Thematic Network (RETICS) programme (RD16/0012/ 0013) (RIER), from Instituto de Salud Carlos III (ISCIII, Spanish Ministry of Economy, Industry and Competitiveness). AM is a recipient of a Miguel Servet fellowship (CP17/00008) from ISCIII (Spanish Ministry of Economy, Industry and Competitiveness). CW is supported by FP7/2007-2013/ERC Advanced Grant (agreement 2012–322698), the Stiftelsen K.G. Jebsen Coeliac Disease Research Centre (Oslo, Norway), and a Spinoza Prize from the Netherlands Organization for Scientific Research (NWO SPI 92-266). This research utilizes resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), National Institute of Child Health and Human Development (NICHD), and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus

  • González-Serna, David
  • Ortiz-Fernández, Lourdes
  • Vargas, Sofía
  • García, Antonio
  • Raya, Enrique
  • Fernández-Gutiérrez, Benjamín
  • López-Longo, Francisco Javier
  • Balsa, Alejandro
  • González-Álvaro, Isidoro
  • Narváez, Javier
  • Gómez-Vaquero, C.
  • Sabio, José Mario
  • García-Portales, Rosa
  • González-Escribano, María Francisca
  • Tolosa-Vilella, Carles
  • Carreira, Patricia E.
  • Kiemeney, Lambertus A.
  • Coenen, Marieke J. H.
  • Witte, Torsten
  • Schneider, Matthias
  • González-Gay, Miguel A.
  • Martín, Javier
A rare variant (BAFF-var) of the tumor necrosis factor superfamily 13b (TNFSF13B) gene has been recently associated with multiple sclerosis (MS) and systemic lupus erythematosus (SLE). The aim of this study was to investigate the association between TNFSF13B BAFF-var and susceptibility to rheumatoid arthritis (RA) and replicate that association in SLE. 6,218 RA patients, 2,575 SLE patients and 4,403 healthy controls from three different countries were included in the study. TNFSF13B BAFF-var was genotyped using TaqMan allelic discrimination assay. PLINK software was used for statistical analyses. TNFSF13B BAFF-var was significantly associated with RA (p = 0.015, OR = 1.21, 95% CI = 1.03–1.41) in the Spanish cohort. A trend of association was observed in the Dutch (p = 0.115) and German (p = 0.228) RA cohorts. A meta-analysis of the three RA cohorts included in this study revealed a statistically significant association (p = 0.002, OR = 1.24, 95% CI = 1.10–1.38). In addition, TNFSF13B BAFF-var was significantly associated with SLE in the Spanish (p = 0.001, OR = 1.41, 95% CI = 1.14–1.74) and the German cohorts (p = 0.030, OR = 1.86, 95% CI = 1.05–3.28), with a statistically significant p-value obtained in the meta-analysis (p = 0.0002, OR = 1.46, 95% CI = 1.09–2.32). The results obtained confirm the known association of TNFSF13B BAFF-var with SLE and, for the first time, demonstrate that this variant contributes to susceptibility to RA., This work was supported by the following grants: P12-BIO-1395 from Consejería de Innovación, Ciencia y Tecnología, Junta de Andalucía (Spain), and the Cooperative Research Thematic Network (RETICS) program, RD16/0012/0004 (RIER), from Instituto de Salud Carlos III (ISCIII, Health Ministry, Madrid, Spain). DGS was supported by the Spanish Ministry of Economy and Competitiveness through the program FPI (SAF2015-66761-P)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The potential role of genomic medicine in the therapeutic management of rheumatoid arthritis

  • Acosta-Herrera, Marialbert
  • González-Serna, David
  • Martín, Javier
© The Author(s)., During the last decade, important advances have occurred regarding understanding of the pathogenesis and treatment of rheumatoid arthritis (RA). Nevertheless, response to treatment is not universal, and choosing among different therapies is currently based on a trial and error approach. The specific patient’s genetic background influences the response to therapy for many drugs: In this sense, genomic studies on RA have produced promising insights that could help us find an effective therapy for each patient. On the other hand, despite the great knowledge generated regarding the genetics of RA, most of the investigations performed to date have focused on identifying common variants associated with RA, which cannot explain the complete heritability of the disease. In this regard, rare variants could also contribute to this missing heritability as well as act as biomarkers that help in choosing the right therapy. In the present article, different aspects of genetics in the pathogenesis and treatment of RA are reviewed, from large-scale genomic studies to specific rare variant analyses. We also discuss the shared genetic architecture existing among autoimmune diseases and its implications for RA therapy, such as drug repositioning, This work was supported by the Cooperative Research Thematic Network (RETICS) program (RD16/0012/0013) (RIER) from Instituto de Salud Carlos III (ISCIII, Spanish Ministry of Economy, Industry, and Competitiveness) and the Spanish Ministry of Economy and Competitiveness (SAF2015-66761-P)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Analysis of the genetic component of systemic sclerosis in Iranian and Turkish populations through a genome-wide association study

  • González-Serna, David
  • López-Isac, Elena
  • Yilmaz, Neslihan
  • Gharibdoost, Farhad
  • Jamshidi, Ahmadreza
  • Kavosi, Hoda
  • Poursani, Shiva
  • Farsad, Faraneh
  • Direskeneli, Haner
  • Saruhan-Direskeneli, Güher
  • Vargas, Sofía
  • Sawalha, A. H.
  • Brown, Matthew A.
  • Yavuz, Sule
  • Mahmoudi, Mahdi
  • Martín, J.
Objectives. SSc is an autoimmune disease characterized by alteration of the immune response, vasculopathy and fibrosis. Most genetic studies on SSc have been performed in European-ancestry populations. The aim of this study was to analyse the genetic component of SSc in Middle Eastern patients from Iran and Turkey through a genome-wide association study. Methods. This study analysed data from a total of 834 patients diagnosed with SSc and 1455 healthy controls from Iran and Turkey. DNA was genotyped using high-throughput genotyping platforms. The data generated were imputed using the Michigan Imputation Server, and the Haplotype Reference Consortium as a reference panel. A meta-analysis combining both case-control sets was conducted by the inverse variance method. Results. The highest peak of association belonged to the HLA region in both the Iranian and Turkish populations. Strong and independent associations between the classical alleles HLA-DRB1*11:04 [P = 2.10 x 10(-24), odds ratio (OR) = 3.14] and DPB1*13:01 (P = 5.37 x 10(-14), OR = 5.75) and SSc were observed in the Iranian population. HLA-DRB1*11:04 (P = 4.90 x 10(-11), OR = 2.93) was the only independent signal associated in the Turkish cohort. An omnibus test yielded HLA-DRB1 58 and HLA-DPB1 76 as relevant amino acid positions for this disease. Concerning the meta-analysis, we also identified two associations close to the genome-wide significance level outside the HLA region, corresponding to IRF5-TNPO3 rs17424921-C (P = 1.34 x 10(-7), OR = 1.68) and NFKB1 rs4648133-C (P = 3.11 x 10(-7), OR = 1.47). Conclusion. We identified significant associations in the HLA region and suggestive associations in IRF5-TNPO3 and NFKB1 loci in Iranian and Turkish patients affected by SSc through a genome-wide association study and an extensive HLA analysis., This work was supported by the Spanish Ministry of Economy and Competitiveness [SAF2015-66761-P to J.M. and SAF2015-66761-P to D.G.S.] and The Cooperative Research Thematic Network (RETICS) program, from the Instituto de Salud Carlos III (ISCIII, Health Ministry, Madrid, Spain) [RD16/0012/0004]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases

  • Acosta-Herrera, Marialbert
  • Kerick, Martin
  • González-Serna, David
  • Wijmenga, Cisca
  • Franke, Andre
  • Gregersen, Peter K.
  • Padyukov, Leonid
  • Worthington, J.
  • Vyse, T. J.
  • Alarcón-Riquelme, M. E.
  • Mayes, Maureen D.
  • Martín, J.
  • Miller, Frederick W.
  • Chen, Wei
  • O'Hanlon, Terrance P.
  • Cooper, Robert G.
  • Vencovsky, Jiri
  • Rider, Lisa G
  • Danko, Katalin
  • Wedderburn, Lucy R.
  • Lundberg, Ingrid E.
  • Pachman, Lauren M.
  • Reed, Ann M.
  • Ytterberg, Steven R.
  • Selva-O'Callaghan, Albert
  • Radstake, Timothy R.
  • Isenberg, David A
  • Chinoy, Hector
  • Ollier, William E. R
  • Scheet, Paul
  • Peng, Bo
  • Lee, Annette T.
  • Lamb, Janine A.
  • Amos, Christopher I.
  • Denton, Christopher
  • Hilton-Jones, David
  • Plotz, Paul H.
  • Varsani, Hemlata
  • Radstake, Timothy R. D. J.
  • Gorlova, Olga
  • Rueda, B.
  • Martín, J. E.
  • Alizadeh, B. Z.
  • Palomino-Morales, Rogelio
  • Coenen, Marieke J. H.
  • Vonk, Madelon C.
  • Voskuyl, Alexandre E.
  • Scheurwegh, Annemie J.
  • Broen, Jasper C.
  • van Riel, Piet L. C. M.
  • van 't Slot, Rubén
  • Italiaander, Annet
  • Ophoff, Roel A.
  • Riemekasten, Gabriela
  • Hunzelmann, Nicolas
  • Simeón, Carmen P.
  • Ortego-Centeno, Norberto
  • González-Gay, Miguel A.
  • González-Escribano, María Francisca
  • Airó, Paolo
  • van Laar, Jaap
  • Herrick, A.
  • Hesselstrand, Roger
  • Smith, Vanessa
  • de Keyser, Filip
  • Houssiau, Fredric
  • Chee, Meng May
  • Madhok, Rajan
  • Shiels, Paul
  • Westhovens, Rene
  • Kreuter, A.
  • Kiener, Hans
  • de Baere, Elfride
  • Witte, Torsten
  • Klareskog, Lars
  • Beretta, Lorenzo
  • Scorza, Rafaella
  • Lie, Benedicte A.
  • Hoffmann-Vold, A. M.
  • Carreira, Patricia E.
  • Varga, John
  • Hinchcliff, Monique
  • Lee, Annette T.
  • Ying, Jun
  • Han, Younghun
  • Weng, Shih-Feng
  • Wigley, Fredrick M.
  • Hummers, L. K.
  • Nelson, J. Lee
  • Agarwal, Sandeep K.
  • Assassi, Shervin
  • Gourh, Pravitt
  • Tan, Filemon K.
  • Koeleman, B. P.
  • Arnett, F. C.
  • Myositis Genetics Consortium
  • Scleroderma Genetics Consortium.
Funded by EU/EFPIA Innovative Medicines Initiative Joint Undertaking PRECISESADS (115565), The Spanish Ministry of Economy Industry and Competitiveness (SAF2015-66761-P), The Regional Ministry of Innovation, Science and Technologies of the Andalusian Regional Government (P12-BIO-1395) and Juan de la Cierva fellowship (FJCI-2015-24028). This research was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways.

  • López-Isac, Elena
  • Acosta-Herrera, Marialbert
  • Kerick, Martin
  • Assassi, Shervin
  • Satpathy AT
  • Granja, J.
  • Mumbach, Maxwell R.
  • Beretta, Lorenzo
  • Simeón, Carmen P.
  • Carreira, Patricia E.
  • Ortego-Centeno, Norberto
  • Castellví, I.
  • Bossini-Castillo, Lara
  • Carmona, Francisco David
  • Orozco, Gisela
  • Hunzelmann, Nicolas
  • Distler, Jörg H. W.
  • Franke, Andre
  • Lunardi, C.
  • Moroncini, G
  • Gabrielli, Armando
  • Vries-Bouwstra, Jeska K. de
  • Wijmenga, C
  • Koeleman, B. P.
  • Nordin, A
  • Padyukov, L
  • Hoffmann-Vold, A. M.
  • Lie, B
  • European Scleroderma Group¿
  • Proudman, Susanna
  • Stevens, W
  • Nikpour, M
  • Australian Scleroderma Interest Group (ASIG)
  • Vyse, T
  • Herrick, A.
  • Worthington, J
  • Denton, Christopher
  • Allanore, Yannick
  • Brown, Matthew A.
  • Radstake, Timothy R. D. J.
  • Fonseca, Carmen
  • Chang, HY
  • Mayes, Maureen D.
  • Martín, J.
Systemic sclerosis (SSc) is an autoimmune disease that shows one of the highest mortality rates among rheumatic diseases. We perform a large genome-wide association study (GWAS), and meta-analysis with previous GWASs, in 26,679 individuals and identify 27 independent genome-wide associated signals, including 13 new risk loci. The novel associations nearly double the number of genome-wide hits reported for SSc thus far. We define 95% credible sets of less than 5 likely causal variants in 12 loci. Additionally, we identify specific SSc subtype-associated signals. Functional analysis of high-priority variants shows the potential function of SSc signals, with the identification of 43 robust target genes through HiChIP. Our results point towards molecular pathways potentially involved in vasculopathy and fibrosis, two main hallmarks in SSc, and highlight the spectrum of critical cell types for the disease. This work supports a better understanding of the genetic basis of SSc and provides directions for future functional experiments., We thank Sofia Vargas, Sonia García, and Gema Robledo for their excellent technical assistance and all the patients and control donors for their essential collaboration. We thank National DNA Bank Carlos III (University of Salamanca, Spain) that supplied part of the control DNA samples from Spain, WTCCC and EIRA Consortiums, and PopGen 2.0 network. This work was supported by Spanish Ministry of Economy and Competitiveness (grant ref. SAF2015-66761-P), Consejeria de Innovacion, Ciencia y Tecnologia, Junta de Andalucía (P12-BIO-1395), Ministerio de Educación, Cultura y Deporte through the program FPU, Juan de la Cierva fellowship (FJCI-2015-24028), Red de Investigación en Inflamación y Enfermadades Reumaticas (RIER) from Instituto de Salud Carlos III (RD16/0012/0013), and Scleroderma Research Foundation and NIH P50- HG007735 (to H.Y.C.). H.Y.C. is an Investigator of the Howard Hughes Medical Institute. PopGen 2.0 is supported by a grant from the German Ministry for Education and Research (01EY1103). M.D.M and S.A. are supported by grant DoD W81XWH-18-1- 0423 and DoD W81XWH-16-1-0296, respectively
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk.

  • Pouget, J.G.
  • Schizophrenia Working Group of the Psychiatric Genomics Consortium
  • Han, Buhm
  • Wu, Y.
  • Mignot, E.
  • Ollila, H.M.
  • Barker, J.
  • Spain, S, Dand, N
  • Trembath, R.
  • Martín, J.
  • Mayes, Maureen D.
  • Bossini-Castillo, Lara
  • López-Isac, Elena
  • Jin, Y.
  • Santorico, S.A.
  • Spritz, R.A.
  • Hakonarson, H
  • Polychronakos, C.
  • Raychaudhuri, S
  • Knight, J.
Many immune diseases occur at different rates among people with schizophrenia compared to the general population. Here, we evaluated whether this phenomenon might be explained by shared genetic risk factors. We used data from large genome-wide association studies to compare the genetic architecture of schizophrenia to 19 immune diseases. First, we evaluated the association with schizophrenia of 581 variants previously reported to be associated with immune diseases at genome-wide significance. We identified five variants with potentially pleiotropic effects. While colocalization analyses were inconclusive, functional characterization of these variants provided the strongest evidence for a model in which genetic variation at rs1734907 modulates risk of schizophrenia and Crohn’s disease via altered methylation and expression of EPHB4—a gene whose protein product guides the migration of neuronal axons in the brain and the migration of lymphocytes towards infected cells in the immune system. Next, we investigated genome-wide sharing of common variants between schizophrenia and immune diseases using cross-trait LD score regression. Of the 11 immune diseases with available genome-wide summary statistics, we observed genetic correlation between six immune diseases and schizophrenia: inflammatory bowel disease (rg = 0.12 ± 0.03, P = 2.49 × 10−4), Crohn’s disease (rg = 0.097 ± 0.06, P = 3.27 × 10−3), ulcerative colitis (rg = 0.11 ± 0.04, P = 4.05 × 10–3), primary biliary cirrhosis (rg = 0.13 ± 0.05, P = 3.98 × 10−3), psoriasis (rg = 0.18 ± 0.07, P = 7.78 × 10–3) and systemic lupus erythematosus (rg = 0.13 ± 0.05, P = 3.76 × 10–3). With the exception of ulcerative colitis, the degree and direction of these genetic correlations were consistent with the expected phenotypic correlation based on epidemiological data. Our findings suggest shared genetic risk factors contribute to the epidemiological association of certain immune diseases and schizophrenia., This research was supported in part by a number of funding sources. This research uses resources provided by the Genetic Association Information Network (GAIN), obtained from the database of Genotypes and Phenotypes (dbGaP) found at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000021.v3.p2; samples and associated phenotype data for this study were provided by the Molecular Genetics of Schizophrenia Collaboration (PI: Pablo V. Gejman, Evanston Northwestern Healthcare and Northwestern University, Evanston, IL, USA). Fulbright Canada, the Weston Foundation, and Brain Canada through the Canada Brain Research Fund—a public-private partnership established by the Government of Canada (to J.G.P.); the National Research Foundation of Korea (NRF) [grant 2016R1C1B2013126 to B.H.] and the Bio & Medical Technology Development Program of the NRF [grant 2017M3A9B6061852 to B.H.] funded by the Korean government, Ministry of Science and ICT; the Finnish Cultural Foundation and Academy of Finland [grant 309643 to H.M.O.]; the Spanish Ministry of Economy and Competitiveness and P12-BIO-1395 from Consejería de Innovación, Ciencia y Tecnología, Junta de Andalucía (Spain) [grant SAF2015-66761-P to J.M.]; the US National Institutes of Health (NIH) [grants R01AR045584, R01AR056292, X01HG007484 and P30AR057212 to Y.J., S.A.S. and R.S.]; the US NIH [grants N01AR02251 and R01AR05528 to M.D.M.]; the US NIH [grants 1R01AR063759, 1R01AR062886, 1UH2AR067677-01 and U19AI111224-01 to S.R.] and Doris Duke Charitable Foundation [grant 2013097 to S.R.]. Funding for the GAIN schizophrenia sample was provided by the US NIH [grants R01 MH67257, R01 MH59588, R01 MH59571, R01 MH59565, R01 MH59587, R01 MH60870, R01 MH59566, R01 MH59586, R01 MH61675, R01 MH60879, R01 MH81800, U01 MH46276, U01 MH46289, U01 MH46318, U01 MH79469 and U01 MH79470] and the genotyping of samples was provided through GAIN. The funding sources did not influence the study design, data analysis or writing of this manuscript.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn's disease.

  • González-Serna, David
  • Ochoa, Eguzkine
  • López-Isac, Elena
  • Julià, Antonio
  • Degenhardt, Frauke
  • Ortego-Centeno, Norberto
  • Radstake, Timothy R. D. J.
  • Franke, Andre
  • Marsal, Sara
  • Mayes, Maureen D.
  • Martín, J.
  • Márquez, Ana
Genome-wide association studies (GWASs) have identified a number of genetic risk loci associated with systemic sclerosis (SSc) and Crohn’s disease (CD), some of which confer susceptibility to both diseases. In order to identify new risk loci shared between these two immune-mediated disorders, we performed a cross-disease meta-analysis including GWAS data from 5,734 SSc patients, 4,588 CD patients and 14,568 controls of European origin. We identified 4 new loci shared between SSc and CD, IL12RB2, IRF1/SLC22A5, STAT3 and an intergenic locus at 6p21.31. Pleiotropic variants within these loci showed opposite allelic effects in the two analysed diseases and all of them showed a significant effect on gene expression. In addition, an enrichment in the IL-12 family and type I interferon signaling pathways was observed among the set of SSc-CD common genetic risk loci. In conclusion, through the first cross-disease meta-analysis of SSc and CD, we identified genetic variants with pleiotropic effects on two clinically distinct immune-mediated disorders. The fact that all these pleiotropic SNPs have opposite allelic effects in SSc and CD reveals the complexity of the molecular mechanisms by which polymorphisms affect diseases., We thank Sofia Vargas and Gema Robledo for her excellent technical assistance and all the patients and control donors for their essential collaboration. We thank WTCCC (Welcome Trust Case Control Consortium) for the access to GWAS data of Crohn’s disease patients and healthy controls, Banco Nacional de ADN (University of Salamanca, Spain) who supplied part of the control DNA samples, and dbGap for granting access to the IBD Genetics Consortium (IBDGC) Crohn’s Disease GWAS data (phs000130.v1.p1). The IBDGC Crohn’s Disease Genome-Wide Association Study was conducted by the IBDGC Investigators and supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This manuscript was not prepared in collaboration with Investigators of the IBDGC Crohn’s Disease Genome-Wide Association Study and does not necessarily reflect the opinions or views of the IBDGC Crohn’s Disease Genome-Wide Association Study, the NIDDK Central Repositories, or the NIDDK. This work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2015-66761-P; IPT-010000-2010-36, cofunded by the European Regional Development Fund), Consejería de Innovación, Ciencia y Tecnología, Junta de Andalucía (Spain) (P12-BIO-1395) and the Cooperative Research Thematic Network (RETICS) programme (RD16/0012/0013) (RIER) from Instituto de Salud Carlos III (ISCIII, Spanish Ministry of Economy, Industry and Competitiveness). AM is recipient of a Miguel Servet fellowship (CP17/00008) from ISCIII (Spanish Ministry of Economy, Industry and Competitiveness). DGS was supported by the Spanish Ministry of Economy and Competitiveness through the FPI programme (SAF2015-66761-P). This work is part of the Doctoral Thesis “Bases Genéticas de la Esclerosis Sistémica: Integrando Genómica y Transcriptómica”.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Approaching Shared Pathophysiology in Immune-Mediated Diseases through Functional Genomics

  • González-Serna, David
  • Villanueva-Martín, Gonzalo
  • Acosta-Herrera, Marialbert
  • Márquez, Ana
  • Martín, Francisco
© 2020 by the authors., Immune-mediated diseases (IMDs) are complex pathologies that are strongly influenced by environmental and genetic factors. Associations between genetic loci and susceptibility to these diseases have been widely studied, and hundreds of risk variants have emerged during the last two decades, with researchers observing a shared genetic pattern among them. Nevertheless, the pathological mechanism behind these associations remains a challenge that has just started to be understood thanks to functional genomic approaches. Transcriptomics, regulatory elements, chromatin interactome, as well as the experimental characterization of genomic findings, constitute key elements in the emerging understandings of how genetics affects the etiopathogenesis of IMDs. In this review, we will focus on the latest advances in the field of functional genomics, centering our attention on systemic rheumatic IMDs., This work was supported by Red de Investigación en Inflamación y Enfermedades Reumáticas (RIER) from Instituto de Salud Carlos III (RD16/0012/0013). : David Gonzalez-Serna and Gonzalo Villanueva-Martin were supported by the Spanish Ministry of Science and Innovation through the FPI programme (SAF2015-66761-P and RTI2018-101332-B-I00 respectively). Marialbert Acosta-Herrera was funded by the Spanish Ministry of Science and Innovation through the “Juan de la Cierva Incorporación” program (IJC2018-035131-I). Ana Marquez is a recipient of a Miguel Servet fellowship (CP17/00008) from Instituto de Salud Carlos III (Spanish Ministry of Economy, Industry and Competitiveness)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk

  • Moreno-Moral, Aida
  • Bagnati, Marta
  • Koturan, S.
  • Ko, J.H.
  • Fonseca, Carmen
  • Harmston, Nathan
  • Game, Laurence
  • Martín, J.
  • Ong, V.
  • Abraham, David J.
  • Denton, Christopher
  • Behmoaras, Jacques
  • Petretto, E.
Objectives Several common and rare risk variants have been reported for systemic sclerosis (SSc), but the effector cell(s) mediating the function of these genetic variants remains to be elucidated. While innate immune cells have been proposed as the critical targets to interfere with the disease process underlying SSc, no studies have comprehensively established their effector role. Here we investigated the contribution of monocyte-derived macrophages (MDMs) in mediating genetic susceptibility to SSc. Methods We carried out RNA sequencing and genome-wide genotyping in MDMs from 57 patients with SSc and 15 controls. Our differential expression and expression quantitative trait locus (eQTL) analysis in SSc was further integrated with epigenetic, expression and eQTL data from skin, monocytes, neutrophils and lymphocytes. Results We identified 602 genes upregulated and downregulated in SSc macrophages that were significantly enriched for genes previously implicated in SSc susceptibility (P=5×10 -4), and 270 cis-regulated genes in MDMs. Among these, GSDMA was reported to carry an SSc risk variant (rs3894194) regulating expression of neighbouring genes in blood. We show that GSDMA is upregulated in SSc MDMs (P=8.4×10 -4) but not in the skin, and is a significant eQTL in SSc macrophages and lipopolysaccharide/interferon gamma (IFNα)-stimulated monocytes. Furthermore, we identify an SSc macrophage transcriptome signature characterised by upregulation of glycolysis, hypoxia and mTOR signalling and a downregulation of IFNα response pathways. Conclusions Our data further establish the link between macrophages and SSc, and suggest that the contribution of the rs3894194 risk variant to SSc susceptibility can be mediated by GSDMA expression in macrophages., Fundingthis work was supported by the Medical research Council (Mr/M004716/1 to JB and Ep, and Mr/n01121x/1 to JB), by the nMrC (grant CBrG15may062) and duke-nUS Medical School (to Ep), by the Arthritis research UK (19427), Scleroderma & raynaud’s UK and the royal Free Charity (to dJA, Vo and Cpd), and by grant SAF2015 66761 p (to JM)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes

  • Acosta-Herrera, Marialbert
  • Kerick, Martin
  • López-Isac, Elena
  • Assassi, Shervin
  • Beretta, Lorenzo
  • Simeón, Carmen P.
  • Ortego-Centeno, Norberto
  • International SSc Group
  • Proudman, Susanna
  • Australian Scleroderma Interest Group (ASIG)
  • Hunzelmann, Nicolas
  • Moroncini, G
  • Vries-Bouwstra, Jeska K. de
  • Orozco, Gisela
  • Barton, Anne
  • Herrick, A.
  • Terao, Chikashi
  • Allanore, Yannick
  • Brown, Matthew A.
  • Radstake, T. R.
  • Fonseca, Carmen
  • Denton, Christopher
  • Mayes, Maureen D.
  • Martín, Javier
Abstract Objective The greatest genetic effect reported for systemic sclerosis (SSc) lies in the major histocompatibility complex (MHC) locus. Leveraging the largest SSc genome-wide association study, we aimed to fine-map this region to identify novel human leucocyte antigen (HLA) genetic variants associated with SSc susceptibility and its main clinical and serological subtypes. Methods 9095 patients with SSc and 17 584 controls genome-wide genotyped were used to impute and test single-nucleotide polymorphisms (SNPs) across the MHC, classical HLA alleles and their composite amino acid residues. Additionally, patients were stratified according to their clinical and serological status, namely, limited cutaneous systemic sclerosis (lcSSc), diffuse cutaneous systemic sclerosis (dcSSc), anticentromere (ACA), antitopoisomerase (ATA) and anti-RNApolIII autoantibodies (ARA). Results Sequential conditional analyses showed nine SNPs, nine classical alleles and seven amino acids that modelled the observed associations with SSc. This confirmed previously reported associations with HLA-DRB1*11:04 and HLA-DPB1*13:01, and revealed a novel association of HLA-B*08:01. Stratified analyses showed specific associations of HLA-DQA1*02:01 with lcSSc, and an exclusive association of HLA-DQA1*05:01 with dcSSc. Similarly, private associations were detected in HLA-DRB1*08:01 and confirmed the previously reported association of HLA-DRB1*07:01 with ACA-positive patients, as opposed to the HLA-DPA1*02:01 and HLA-DQB1*03:01 alleles associated with ATA presentation. Conclusions This study confirms the contribution of HLA class II and reveals a novel association of HLA class I with SSc, suggesting novel pathways of disease pathogenesis. Furthermore, we describe specific HLA associations with SSc clinical and serological subtypes that could serve as biomarkers of disease severity and progression., This work was supported by the Spanish Ministry of Science and Innovation (grant ref. SAF2015-66761-P and RTI20181013 (32-B-100)), Red de Investigación en Inflamación y Enfermedades Reumáticas from Instituto de Salud Carlos III (RD16/0012/0013) and grants from National Institutes of Health (R01AR073284) and DoD (W81XWH-16-1-0296). MAH was funded by the Spanish Ministry of Science and Innovation through the Juan de la Cierva Incorporacion program (ref. IJC2018-035131-I). GO, AB and ALH were supported by the NIHR Manchester Biomedical Research Centre and Versus Arthritis (grant ref 21754)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

  • López-Isac, E.
  • Acosta-Herrera, M.
  • Kerick, M.
  • Assassi, S.
  • Satpathy, A.T.
  • Granja, J.
  • Mumbach, M.R.
  • Beretta, L.
  • Simeón, C.P.
  • Carreira, P.
  • Ortego-Centeno, N.
  • Castellvi, I.
  • Bossini-Castillo, L.
  • Carmona, F.D.
  • Orozco, G.
  • Hunzelmann, N.
  • Distler, J.H.W.
  • Franke, A.
  • Lunardi, C.
  • Moroncini, G.
  • Gabrielli, A.
  • de Vries-Bouwstra, J.
  • Wijmenga, C.
  • Koeleman, B.P.C.
  • Nordin, A.
  • Padyukov, L.
  • Hoffmann-Vold, A.-M.
  • Lie, B.
  • Ríos, R.
  • Callejas, J.L.
  • Vargas-Hitos, J.A.
  • García-Portales, R.
  • Camps, M.T.
  • Fernández-Nebro, A.
  • González-Escribano, M.F.
  • García-Hernández, F.J.
  • Castillo, M.J.
  • Aguirre, M.A.
  • Gómez-Gracia, I.
  • Fernández-Gutiérrez, B.
  • Rodríguez-Rodríguez, L.
  • García de la Peña, P.
  • Vicente, E.
  • Andreu, J.L.
  • Fernández de Castro, M.
  • López-Longo, F.J.
  • Martínez, L.
  • Fonollosa, V.
  • Guillén, A.
  • Espinosa, G.
  • Tolosa, C.
  • Pros, A.
  • Rodríguez-Carballeira, M.
  • Narváez, F.J.
  • Rubio-Rivas, M.
  • Ortiz-Santamaría, V
  • Madroñero, A.B.
  • González-Gay, M.A.
  • Díaz, B.
  • Trapiella, L.
  • Sousa, A.
  • Egurbide, M.V.
  • Fanlo-Mateo, P.
  • Sáez-Comet, L.
  • Díaz, F.
  • Hernández, V
  • Beltrán, E.
  • Román-Ivorra, J.A.
  • Grau E.
  • Alegre-Sancho, J.J.
  • Freire, M.
  • Blanco-García, F.J.
  • Oreiro, N.
  • Witte, T.
  • Kreuter, A.
  • Riemekasten, G.
  • Airó P.
  • Magro, C.
  • Voskuyl, A.E.
  • Vonk, M.C.
  • Hesselstrand, R.
  • Proudman S.
  • Stevens, W.
  • Nikpour, M.
  • Zochling, J.
  • Sahhar, J.
  • Roddy, J.
  • Nash, P.
  • Tymms, K.
  • Rischmueller, M.
  • Lester, S.
  • Vyse, T.
  • Herrick, A.L.
  • Worthington, J.
  • Denton C.P.
  • Allanore, Y.
  • Brown, M.A.
  • Radstake, T.R.D.J.
  • Fonseca, C.
  • Chang H.Y.
  • Mayes, M.D.
  • Martin, J.
  • European Scleroderma Group
  • Australian Scleroderma Interest Group (ASIG)
Systemic sclerosis (SSc) is an autoimmune disease that shows one of the highest mortality rates among rheumatic diseases. We perform a large genome-wide association study (GWAS), and meta-analysis with previous GWASs, in 26, 679 individuals and identify 27 independent genome-wide associated signals, including 13 new risk loci. The novel associations nearly double the number of genome-wide hits reported for SSc thus far. We define 95% credible sets of less than 5 likely causal variants in 12 loci. Additionally, we identify specific SSc subtype-associated signals. Functional analysis of high-priority variants shows the potential function of SSc signals, with the identification of 43 robust target genes through HiChIP. Our results point towards molecular pathways potentially involved in vasculopathy and fibrosis, two main hallmarks in SSc, and highlight the spectrum of critical cell types for the disease. This work supports a better understanding of the genetic basis of SSc and provides directions for future functional experiments.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

  • González-Serna, D.
  • Ochoa, E.
  • López-Isac, E.
  • Julià, A.
  • Degenhardt, F.
  • Ortego-Centeno, N.
  • Radstake, T.R.D.J.
  • Franke, A.
  • Marsal, S.
  • Mayes, M.D.
  • Martín, J.
  • Márquez, A.
  • Assassi, S.
  • Zhou, X.
  • Tan, F.K.
  • Arnett, F.C.
  • Reveille, J.D.
  • Gorlova, O.
  • Chen, W.V.
  • Ying, J.
  • Gregersen, P.K.
  • Lee, A.T.
  • Voskuyl, A.E.
  • de Vries-Bouwstra, J.
  • Magro-Checa, C.
  • Broen, J.
  • Koeleman, B.P.C.
  • Simeón, C.P.
  • Fonollosa, V.
  • Guillén, A.
  • Carreira, P.
  • Castellví, I.
  • González-Gay, M.A.
  • Ríos, R.
  • Callejas-Rubio, J.L.
  • Vargas-Hitos, J.A.
  • García-Portales, R.
  • Camps, M.T.
  • Fernández-Nebro, A.
  • González-Escribano, M.F.
  • García-Hernández, F.J.
  • Castillo, M.J.
  • Aguirre, M.Á.
  • Gómez-Gracia, I.
  • Rodríguez-Rodríguez, L.
  • Fernández-Gutiérrez, B.
  • de la Peña, P.G.
  • Vicente, E.
  • Andreu, J.L.
  • Fernández de Castro, M.
  • López-Longo, F.J.
  • Martínez, L.
  • Espinosa, G.
  • Tolosa, C.
  • Pros, A.
  • Rodríguez-Carballeira, M.
  • Narváez, F.J.
  • Rubio-Rivas, M.
  • Ortiz-Santamaría, V.
  • Madroñero, A.B.
  • Díaz, B.
  • Trapiella, L.
  • Sousa, A.
  • Egurbide, M.V.
  • Fanlo-Mateo, P.
  • Sáez-Comet, L.
  • Díaz-González, F.
  • Hernández, V.
  • Beltrán, E.
  • Román-Ivorra, J.A.
  • Grau, E.
  • Alegre-Sancho, J.J.
  • Blanco-García, F.J.
  • Oreiro, N.
  • Freire, M.
  • Balsa, A.
  • Ortiz, A.M.
  • Hunzelmann, N.
  • Riemekasten, G.
  • Distler, J.H.W.
  • Witte, T.
  • Airó, P.
  • Beretta, L.
  • Santaniello, A.
  • Bellocchi, C.
  • Lunardi, C.
  • Moroncini, G.
  • Gabrielli, A.
  • Scleroderma, Genetic, Consortium
Genome-wide association studies (GWASs) have identified a number of genetic risk loci associated with systemic sclerosis (SSc) and Crohn’s disease (CD), some of which confer susceptibility to both diseases. In order to identify new risk loci shared between these two immune-mediated disorders, we performed a cross-disease meta-analysis including GWAS data from 5, 734 SSc patients, 4, 588 CD patients and 14, 568 controls of European origin. We identified 4 new loci shared between SSc and CD, IL12RB2, IRF1/SLC22A5, STAT3 and an intergenic locus at 6p21.31. Pleiotropic variants within these loci showed opposite allelic effects in the two analysed diseases and all of them showed a significant effect on gene expression. In addition, an enrichment in the IL-12 family and type I interferon signaling pathways was observed among the set of SSc-CD common genetic risk loci. In conclusion, through the first cross-disease meta-analysis of SSc and CD, we identified genetic variants with pleiotropic effects on two clinically distinct immune-mediated disorders. The fact that all these pleiotropic SNPs have opposite allelic effects in SSc and CD reveals the complexity of the molecular mechanisms by which polymorphisms affect diseases.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

  • López-Isac, Elena|||0000-0001-8806-5148
  • Acosta-Herrera, Marialbert|||0000-0002-9868-6535
  • Kerick, Martin|||0000-0002-6298-4514
  • Assassi, Shervin|||0000-0002-8059-9978
  • Satpathy, Ansuman|||0000-0002-5167-537X
  • Granja, Jeffrey
  • Mumbach, Maxwell|||0000-0002-5570-6663
  • Beretta, Lorenzo|||0000-0002-6529-6258
  • Simeón-Aznar, Carmen Pilar|||0000-0003-3390-9029
  • Carreira, Patricia E.|||0000-0001-8279-3806
  • Ortego-Centeno, Norberto|||0000-0003-2325-0937
  • Castellvi, Ivan|||0000-0002-5410-5807
  • Bossini-Castillo, Lara|||0000-0002-5471-5824
  • Carmona, F. David|||0000-0002-1427-7639
  • Orozco, Gisela|||0000-0002-3479-0448
  • Hunzelmann, Nicolas
  • Distler, Jörg|||0000-0001-7408-9333
  • Franke, Andre|||0000-0003-1530-5811
  • Lunardi, Claudio|||0000-0001-6446-2990
  • Moroncini, Gianluca|||0000-0002-0380-0105
  • Gabrielli, Armando
  • de Vries-Bouwstra, Jeska
  • Wijmenga, Cisca|||0000-0002-5635-1614
  • Koeleman, Bobby|||0000-0001-7749-182X
  • Nordin, Annika|||0000-0003-1976-4679
  • Padyukov, Leonid|||0000-0003-2950-5670
  • Hoffmann-Vold, A.M.|||0000-0001-6467-7422
  • Lie, Benedicte A.|||0000-0002-1159-7004
  • Ríos, Raquel
  • Callejas Rubio, Jose Luis|||0000-0002-1653-0087
  • Vargas-Hitos, José Antonio|||0000-0002-0596-8710
  • García-Portales, Rosa
  • Camps, María Teresa
  • Fernández-Nebro, Antonio|||0000-0002-2962-9844
  • González-Escribano, Maria Francisca
  • García-Hernández, Francisco Jose|||0000-0002-2600-0485
  • Castillo, María Jesús
  • Aguirre, Mª Angeles|||0000-0002-5653-4293
  • Gómez-Gracia, Inmaculada
  • Fernández-Gutiérrez, B.|||0000-0002-6126-8786
  • Rodríguez-Rodríguez, L.
  • García de la Peña, Paloma|||0000-0001-6586-6903
  • Vicente-Rabaneda, Esther Francisca
  • Andréu, José Luis|||0000-0002-6002-1239
  • Fernández de Castro, Mónica
  • López Longo, Francisco Javier
  • Martínez, Lina
  • Fonollosa, Vicenç
  • Guillén, Alfredo Chávez
  • Espinosa, Gerard|||0000-0003-1336-0163
  • Tolosa Vilella, Carles|||0000-0002-3379-4412
  • Pros, Ana|||0000-0003-0266-0531
  • Rodríguez-Carballeira, M.
  • Narváez, Francisco J.
  • Rubio Rivas, Manuel|||0000-0002-9548-1374
  • Ortiz-Santamaría, None
  • Madroñero, A.B.
  • Gonzalez-Gay, MA.|||0000-0002-7924-7406
  • Díaz, Bernardino
  • Trapiella, L.
  • Sousa, A.
  • Egurbide, María Victoria
  • Fanlo-Mateo, P.
  • Sáez-Comet, Luis|||0000-0002-9868-6498
  • Díaz, F.
  • Hernández, None
  • Beltrán, E.
  • Román-Ivorra, J.A.
  • Grau, E.
  • Alegre-Sancho, Juan José|||0000-0003-1641-0875
  • Freire, M.
  • Blanco-García, F.J.|||0000-0001-9821-7635
  • Oreiro, N.
  • Witte, Torsten
  • Kreuter, A.
  • Riemekasten, G.|||0000-0002-5406-2464
  • Airò, Paolo
  • Magro-Checa, César
  • Voskuyl, A.E.|||0000-0002-9699-1827
  • Vonk, Madelon C.
  • Hesselstrand, Roger
  • Proudman, Susanna
  • Stevens, Wendy
  • Nikpour, Mandana
  • Zochling, Jane M.
  • Sahhar, Joanne|||0000-0003-4220-2906
  • Roddy, Janet
  • Nash, Peter
  • Tymms, Kathleen
  • Rischmueller, Maureen
  • Lester, S.
  • Vyse, Timothy|||0000-0003-1123-1464
  • Herrick, Ariane|||0000-0003-4941-7926
  • Worthington, Jane
  • Denton, Christopher P.
  • Allanore, Yannick|||0000-0002-6149-0002
  • Brown, Matthew A.|||0000-0003-0538-8211
  • Radstake, Timothy R. D. J.
  • Fonseca, Carmen
  • Chang, Howard Y.
  • Mayes, Maureen D.|||0000-0001-5070-2535
  • Martín, Javier|||0000-0002-2202-0622
Systemic sclerosis (SSc) is an autoimmune disease that shows one of the highest mortality rates among rheumatic diseases. We perform a large genome-wide association study (GWAS), and meta-analysis with previous GWASs, in 26,679 individuals and identify 27 independent genome-wide associated signals, including 13 new risk loci. The novel associations nearly double the number of genome-wide hits reported for SSc thus far. We define 95% credible sets of less than 5 likely causal variants in 12 loci. Additionally, we identify specific SSc subtype-associated signals. Functional analysis of high-priority variants shows the potential function of SSc signals, with the identification of 43 robust target genes through HiChIP. Our results point towards molecular pathways potentially involved in vasculopathy and fibrosis, two main hallmarks in SSc, and highlight the spectrum of critical cell types for the disease. This work supports a better understanding of the genetic basis of SSc and provides directions for future functional experiments.